Navigation Links
Techne Corporation Announces the Retirement of G. Arthur Herbert, a Member of Its Board of Directors
Date:5/19/2009

MINNEAPOLIS, May 19 /PRNewswire-FirstCall/ -- G. Arthur Herbert, a Techne Corporation (Nasdaq: TECH) Director and member of its Audit Committee, Executive Compensation Committee and Nomination and Governance Committee, announced today that he is planning to retire at the end of his current term on October 29, 2009. Techne's shareholders reelect Directors on an annual basis. Mr. Herbert has decided to withhold his name for re-nomination as a Director for fiscal year 2010.

Mr. Herbert has been a Techne Director since 1989 and an investor in R&D Systems since 1980. He has had a very successful and rewarding 60 plus year working career as a U.S. Naval Officer, a venture capitalist, a management consultant and as a Director in numerous private and public companies. He received his Masters in Business Administration from Harvard University and Bachelor of Science in Engineering from the United States Naval Academy.

Mr. Thomas E. Oland, Techne's Chairman and CEO, said, "I have known and have had the privilege of working with Art Herbert for over 28 years. As a Techne Director he has been very influential and mentoring and took a personal interest in the development of our staff at all levels. He is a man of high integrity and honesty who acted in the best interests of our shareholders while simultaneously being a strong advocate for our employees. He is genuinely a very sincere and good man who is beloved by all of us including Directors and staff. We will miss him terribly but wish him good health and great happiness in his retirement years."

Techne Corporation has two operating subsidiaries: Research and Diagnostic Systems, Inc. (R&D Systems) of Minneapolis, Minnesota and R&D Systems Europe, Ltd. (R&D Europe) of Abingdon, England. R&D Systems is a specialty manufacturer of biological products. R&D Systems has two subsidiaries, BiosPacific, Inc. (BiosPacific), located in Emeryville, California and R&D Systems China Co. Ltd., (R&D China), located in Shanghai, China. BiosPacific is a worldwide supplier of biologics to manufacturers of in vitro diagnostic systems and immunodiagnostic kits. R&D China and R&D Europe distribute biotechnology products.


'/>"/>
SOURCE Techne Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Techne Corporation Announces Share Repurchase Authorization
2. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2008
3. Techne Corporation Releases Unaudited Fourth Quarter Results for Fiscal Year 2008
4. Techne Corporation Releases Unaudited First Quarter Results for Fiscal Year 2009
5. Techne Corporation Declares Dividend
6. Techne Corporation Declares Dividend and Announces an Increase in Its Share Repurchase Program
7. Techne Corporation Releases Unaudited Third Quarter Results for Fiscal Year 2009
8. Techne Corporation Announces That John L. Higgins has Accepted a Seat on Technes Board
9. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
10. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
11. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Israel , April 20, 2017  BrainStorm ... stem cell technologies for neurodegenerative diseases, announced today that ... Alliance for Regenerative Medicine,s (ARM) 5 th Annual Cell ... at 09:40 EDT in Boston . ... Chief Medical Officer & Chief Operating Officer, will participate in ...
(Date:4/19/2017)... Yorba Linda, Ca (PRWEB) , ... April 18, 2017 , ... ... highlight new technological advances. This webinar, which is part of the Protein and ... NxT Flow Cytometer and outline where this technology fits in current and future applications. ...
(Date:4/19/2017)... ... 2017 , ... Nobilis Therapeutics Announces Completion of Landmark NBTX-001 Clinical ... in its Upcoming Post Traumatic Stress Disorder Trial , Nobilis Therapeutics, Inc. ... efficacy of its NBTX-001, a xenon-based therapeutic in the treatment of Panic Disorder. ...
(Date:4/19/2017)... ... April 19, 2017 , ... As part of the ... novices as well as experienced users, attendees will gain a better understanding of ... , Hemostasis testing quality is determined by preanalytical variables which encompass patient ...
Breaking Biology Technology:
(Date:3/9/2017)... , March 9, 2017 4Dx has ... World Lung Imaging Workshop at the University of Pennsylvania. ... invited to deliver the latest data to world leaders ... event brings together leaders at the forefront of the ... lung imaging. "The quality of the ...
(Date:3/7/2017)... -- Brandwatch , the leading social intelligence company, today announces ... to uncover insights to support its reporting, help direct future campaigns, ... leading youth charity will be using Brandwatch Analytics social listening and ... understanding of the topics and issues that are a priority for ... "Until ...
(Date:3/6/2017)... March 6, 2017 Mintigo , ... today announced Predictive Sales Coach TM , its ... sales intelligence into Salesforce. This unique AI application ... sales organizations with deep knowledge of their customers ... intelligent engagement. Predictive Sales Coach extends Mintigo,s existing ...
Breaking Biology News(10 mins):